OmicsDI
Toggle navigation
Browse
Submit Data
Databases
API
Advanced
Search
16
Results
Show all
Save search
Copy query
Show results for
Unknown
(16)
Publication Date
Release Date
2023
(3)
2025
(2)
2024
(2)
2022
(2)
2021
(2)
2010
(2)
2018
(1)
2017
(1)
2013
(1)
Previous
page
1 / 2
You're on page
1
page
2
Next
page
Sort
by:
Relevance
Page size
10
Hundreds of variants clustered in genomic loci and biological pathways affect human height.
Not available
S-EPMC2955183
|
biostudies-literature
Cite
Association analyses of 249,796 individuals reveal 18 new loci associated with body mass index.
Not available
S-EPMC3014648
|
biostudies-literature
Cite
Genome-wide meta-analysis identifies 11 new loci for anthropometric traits and provides insights into genetic architecture.
Not available
S-EPMC3973018
|
biostudies-literature
Cite
Refractive Error Change and Overminus Lens Therapy for Childhood Intermittent Exotropia.
Not available
S-EPMC10958385
|
biostudies-literature
Cite
Identification of ten variants associated with risk of estrogen-receptor-negative breast cancer.
Not available
S-EPMC5808456
|
biostudies-literature
Cite
Prospects for observing and localizing gravitational-wave transients with Advanced LIGO, Advanced Virgo and KAGRA.
Not available
S-EPMC5920066
|
biostudies-literature
Cite
Eight-Year Outcomes of Bilateral Lateral Rectus Recessions versus Unilateral Recession-Resection in Childhood Basic-Type Intermittent Exotropia.
Not available
S-EPMC10841051
|
biostudies-literature
Cite
Baricitinib in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial and updated meta-analysis.
Not available
S-EPMC9333998
|
biostudies-literature
Cite
Higher dose corticosteroids in patients admitted to hospital with COVID-19 who are hypoxic but not requiring ventilatory support (RECOVERY): a randomised, controlled, open-label, platform trial.
Not available
S-EPMC10156147
|
biostudies-literature
Cite
Empagliflozin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial.
Not available
S-EPMC10957483
|
biostudies-literature
Cite
Previous
page
1 / 2
You're on page
1
page
2
Next
page
Sort
by:
Relevance
Page size
10
OmicsDI
is part of the ELIXIR infrastructure
OmicsDI is an Elixir interoperability service.
Learn more ›
Tweets